Literature DB >> 21605821

Pemphigus and quality of life.

Shien-Ning Chee1, Dédée F Murrell.   

Abstract

Measuring the impact of disease on quality of life (QOL) is important for evaluating effectiveness of care and capturing aspects of health that may not correlate with clinical severity. Few QOL studies have been conducted on pemphigus, and a disease-specific QOL questionnaire for this condition has not been developed. The 5 previous studies of the effect of pemphigus on QOL used generic health or skin-specific measures. These measures have limitations, and results from these studies have sometimes been conflicting. The development of a disease-specific measure for pemphigus would allow for better monitoring of patients' QOL and improve management.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21605821     DOI: 10.1016/j.det.2011.03.009

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  8 in total

1.  Low-level laser therapy on the treatment of oral and cutaneous pemphigus vulgaris: case report.

Authors:  Eliana Maria Minicucci; Hélio Amante Miot; Silvia Regina Catharino Sartori Barraviera; Luciana Almeida-Lopes
Journal:  Lasers Med Sci       Date:  2012-04-27       Impact factor: 3.161

2.  Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris.

Authors:  Massimo Radin; Dario Roccatello; Simone Baldovino; Savino Sciascia
Journal:  BMJ Case Rep       Date:  2018-05-30

Review 3.  Autoimmune blistering diseases in females: a review.

Authors:  Cathy Y Zhao; Dédée F Murrell
Journal:  Int J Womens Dermatol       Date:  2015-02-26

Review 4.  The effects of autoimmune blistering diseases on work productivity: A review.

Authors:  Esther Q Wang; M Adriana Castrillón Velásquez; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-02-09

Review 5.  Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications.

Authors:  Meropi Karakioulaki; Dedee F Murrell; Aikaterini Kyriakou; Aikaterini Patsatsi
Journal:  Int J Womens Dermatol       Date:  2022-10-07

6.  The Risk of Depression in Patients with Pemphigus: A Nationwide Cohort Study in Taiwan.

Authors:  Yi-Min Hsu; Hsin-Yu Fang; Cheng-Li Lin; Shwn-Huey Shieh
Journal:  Int J Environ Res Public Health       Date:  2020-03-17       Impact factor: 3.390

7.  Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus.

Authors:  Rebecca L Krain; Carolyn J Kushner; Meera Tarazi; Rebecca G Gaffney; Andrea C Yeguez; Danielle E Zamalin; David R Pearson; Rui Feng; Aimee S Payne; Victoria P Werth
Journal:  Front Immunol       Date:  2019-11-06       Impact factor: 7.561

8.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.